Ocular Therapeutix

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Ocular Therapeutix 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About OCUL

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. 

CEO
Pravin U. Dugel
CEOPravin U. Dugel
Employees
325
Employees325
Headquarters
Bedford, Massachusetts
HeadquartersBedford, Massachusetts
Founded
2006
Founded2006
Employees
325
Employees325

OCUL Key Statistics

Market cap
1.38B
Market cap1.38B
Price-Earnings ratio
-4.31
Price-Earnings ratio-4.31
Dividend yield
—
Dividend yield—
Average volume
2.65M
Average volume2.65M
High today
$6.66
High today$6.66
Low today
$6.27
Low today$6.27
Open price
$6.51
Open price$6.51
Volume
2.34M
Volume2.34M
52 Week high
$16.44
52 Week high$16.44
52 Week low
$6.00
52 Week low$6.00

Stock Snapshot

The current Ocular Therapeutix(OCUL) stock price is $6.40, with a market capitalization of 1.38B. The stock trades at a price-to-earnings (P/E) ratio of -4.31.

As of 2026-11-13, Ocular Therapeutix(OCUL) stock has fluctuated between $6.27 and $6.66. The current price stands at $6.40, placing the stock +2.1% above today's low and -3.9% off the high.

The Ocular Therapeutix(OCUL)'s current trading volume is 2.34M, compared to an average daily volume of 2.65M.

In the last year, Ocular Therapeutix(OCUL) shares hit a 52-week high of $16.44 and a 52-week low of $6.00.

In the last year, Ocular Therapeutix(OCUL) shares hit a 52-week high of $16.44 and a 52-week low of $6.00.

OCUL News

Simply Wall St 3d
Ocular Therapeutix Missed Q3 Estimates As AXPAXLI Progressed, Is The Upside Already Priced In? - Simply Wall St

...

Ocular Therapeutix Missed Q3 Estimates As AXPAXLI Progressed, Is The Upside Already Priced In? - Simply Wall St
TipRanks 3d
Ocular Therapeutix Earnings Call Highlights AXPAXLI Momentum

Ocular Therapeutix Inc ((OCUL)) has held its Q3 earnings call. Read on for the main highlights of the call. Ocular Therapeutix delivered a strongly positive ea...

Analyst ratings

100%

of 13 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own OCUL. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.